Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,369.00

Mettler-Toledo International (NYSE:MTD) had its price target increased by Robert W. Baird from $1,362.00 to $1,369.00 in a report issued on Monday,Benzinga reports. The firm currently has a neutral rating on the medical instruments supplier’s stock.

Several other brokerages have also commented on MTD. Wells Fargo & Company dropped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Stifel Nicolaus lowered their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their target price for the company from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their target price for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Wolfe Research began coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and an average price target of $1,368.00.

Mettler-Toledo International Stock Down 1.4 %

Shares of MTD opened at $1,313.20 on Monday. The company’s fifty day moving average is $1,281.95 and its 200-day moving average is $1,341.62. Mettler-Toledo International has a 12 month low of $1,133.46 and a 12 month high of $1,546.93. The firm has a market cap of $27.71 billion, a price-to-earnings ratio of 32.40, a price-to-earnings-growth ratio of 4.80 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. As a group, research analysts predict that Mettler-Toledo International will post 41.94 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now directly owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds and other institutional investors have recently made changes to their positions in MTD. Norges Bank bought a new position in shares of Mettler-Toledo International during the 4th quarter worth about $372,954,000. Proficio Capital Partners LLC bought a new position in shares of Mettler-Toledo International during the 4th quarter worth about $163,216,000. International Assets Investment Management LLC lifted its holdings in shares of Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after acquiring an additional 89,922 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Mettler-Toledo International by 53.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 214,281 shares of the medical instruments supplier’s stock worth $262,211,000 after acquiring an additional 74,187 shares during the period. Finally, Seilern Investment Management Ltd bought a new position in shares of Mettler-Toledo International during the 4th quarter worth about $89,221,000. 95.07% of the stock is owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.